Circulating miR-23b as a Novel Biomarker for Early Risk Stratification After ST-Elevation Myocardial Infarction

BACKGROUND: miR-23b overexpression can promote cardiomyocyte apoptosis and reduce cell growth under hypoxic conditions, suggesting that miR-23b acts as a biomarker for ST-elevation myocardial infarction (STEMI). The aim of this study was to investigate the effect of miR-23b on STEMI patients. MATERI...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jungang, Li, Yaxing, Zhao, Qingzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2018
Materias:
Lab/In Vitro Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866732/
https://www.ncbi.nlm.nih.gov/pubmed/29535290
http://dx.doi.org/10.12659/MSM.908060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866732/
https://www.ncbi.nlm.nih.gov/pubmed/29535290
http://dx.doi.org/10.12659/MSM.908060

Ejemplares similares